Fibromyalgia drug maker Jazz Pharmaceuticals enjoyed stock market success as shares of Jazz Pharmaceuticals Inc. jumped Wednesday after federal health officials said one of its drugs appears effective for treating a chronic pain disorder. The Food and Drug Administration posted its review online, saying Jazz's drug sodium oxybate effectively treated pain from fibromyalgia in two company-run ...

Shares of Jazz Pharmaceuticals Inc. jumped Wednesday after federal health officials said one of its drugs appears effective for treating a chronic pain disorder.

Cypress Bioscience, Inc., a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system disorders, announced that it is discontinuing its rights under its agreement with Forest Laboratories to co-promote Savella, its drug for fibromyalgia.

SAN DIEGO, CA--(Marketwire - August 6, 2010) - Cypress Bioscience, Inc. ( NASDAQ : CYPB ), a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system disorders, today announced that its Board of Directors has unanimously concluded that the unsolicited, non-binding proposal by Ramius LLC to acquire all of the outstanding shares of Cypress common stock ...

Cypress Bioscience, Inc., a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system disorders, today announced that it is discontinuing its rights under its agreement with Forest Laboratories to co-promote Savella�, its drug for fibromyalgia